Baseline characteristic | Value |
---|---|
Female | 13 (52 %) |
Age (years) | 53 (13) |
Disease duration (months) | 9.0 (7.0–15.0) |
ESR (mm/hour) | 5.0 (2.0–7.5) |
CRP (mg/L) | 2.5 (1.0–5.0) |
VAS general health (0–100 mm) | 5.0 (1.0–24.5) |
Tender joint count | 0 |
Swollen joint count | 0 |
DAS in 44 joints | 0.7 (0.3) |
2011 Boolean ACR/EULAR remission | 18 (72 %) |
ACPA-positive | 18 (72 %) |
RF-positive | 16 (64 %) |
Medication | |
MTX | 12 (48 %) |
MTX + SSZ | 8 (32 %) |
LFL | 1 (4 %) |
MTX + etanercept | 2 (8 %) |
MTX + SSZ + etanercept | 2 (8 %) |
Prednisolone (maximum 7.5 mg per day) | 16 (64 %) |